Literature DB >> 6472938

Tissue carnitine reserves of newborn infants.

J P Shenai, P R Borum.   

Abstract

This study assessed the tissue reserves of carnitine at birth in a group of neonates (n = 22) of varying gestational age dying within 24 h of birth, prior to possible changes in carnitine status induced by postnatal intervention. Tissue carnitine concentration was highest in the muscle in each infant. The mean (+/- SD) muscle carnitine concentration of 8.4 +/- 3.6 nmol/mg noncollagen protein (NCP) in very immature infants (less than or equal to 1000 g birth weight) was significantly lower than the corresponding mean (+/- SD) values of 14.0 +/- 3.2 nmol/mg NCP in larger preterm infants (1001-2500 g; P less than 0.01) and 19.4 +/- 2.6 nmol/mg NCP in term infants (greater than or equal to 2501 g; P less than 0.001). Muscle carnitine concentration correlated positively with gestational age (r = 0.832; P less than 0.001) and with body dimensions. Liver and heart carnitine concentrations did not correlate significantly with gestation or body dimensions. The mean (+/- SD) liver carnitine concentration for all the neonates as a group was 4.1 +/- 1.5 nmol/mg NCP. The mean (+/- SD) heart carnitine concentration was 4.7 +/- 1.3 nmol/mg NCP. In comparison to adult controls, tissue carnitine concentrations were markedly lower in neonates, particularly in immature newborns. These data suggest that newborn infants, especially premature babies, are born with limited tissue reserves of carnitine and are therefore at an increased risk for developing carnitine deficiency and its adverse effects in the postnatal period, particularly if maintained on carnitine-free intravenous nutrition for prolonged periods of time.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6472938     DOI: 10.1203/00006450-198407000-00024

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  In preterm infants, does the supplementation of carnitine to parenteral nutrition improve the following clinical outcomes: Growth, lipid metabolism and apneic spells?: Part B: Clinical commentary.

Authors:  John E Van Aerde
Journal:  Paediatr Child Health       Date:  2004-10       Impact factor: 2.253

Review 2.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

3.  Amino acid and acylcarnitine profiles in premature neonates: a pilot study.

Authors:  Iman Mandour; Dina El Gayar; Maha Amin; Tarek Mohamed Farid; Aliaa Adel Ali
Journal:  Indian J Pediatr       Date:  2013-02-13       Impact factor: 1.967

4.  The Urinary Metabolome of Healthy Newborns.

Authors:  Yamilé López-Hernández; Juan José Oropeza-Valdez; Jorge O Blanco-Sandate; Ana Sofia Herrera-Van Oostdam; Jiamin Zheng; An Chi Guo; Victoria Lima-Rogel; Rahmatollah Rajabzadeh; Mariana Salgado-Bustamante; Jesus Adrian-Lopez; C G Castillo; Emilia Robles Arguelles; Joel Monárrez-Espino; Rupasri Mandal; David S Wishart
Journal:  Metabolites       Date:  2020-04-23

Review 5.  Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.

Authors:  Gregory Guthrie; Douglas Burrin
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

6.  Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches.

Authors:  Li Yue; Xuexin Lu; Phyllis A Dennery; Hongwei Yao
Journal:  Redox Biol       Date:  2021-08-13       Impact factor: 11.799

Review 7.  Carnitine supplementation for preterm infants with recurrent apnea.

Authors:  M Kumar; N S Kabra; B Paes
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

8.  Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.

Authors:  Srinivas Sonne; Prem S Shekhawat; Dietrich Matern; Vadivel Ganapathy; Leszek Ignatowicz
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.